Our end-to-end CDMO services bridge the gap between scientific potential and real-world application, ensuring that innovators at biotech organizations can bring their life-saving radiotherapies to market and patients receive timely, cutting-edge care.
With Nucleus RadioPharma as your dedicated partner, you can:
Our flexible approach allows us to adapt to diverse client needs across the entire spectrum of drug development and manufacturing.
No matter where you are on your targeted radiotherapy journey, you’ll receive optimal services that rapidly advance your program—we’re your dedicated partner every step of the way.
There may only be days, or sometimes even hours, to manufacture, release, ship, and administer a dose to a patient.
Without the proper planning or resources, you may not be able to reach patients in time and, ultimately, waste doses.
With these unique demands in mind, we’re building our development and manufacturing facilities in proximity to prominent destination medical centers and key distribution hubs.
Our growing national manufacturing footprint and interconnected resource network allow your organization to reliably and rapidly produce and deliver radiotherapies.
Production is scheduled to begin in Q4 2024 at our newly opened Rochester, MN facility.
